Skip to main content
Premium Trial:

Request an Annual Quote

GenomeDx Biosciences Closes Series A Funding Round

NEW YORK (GenomeWeb News) – Vancouver-based molecular diagnostics technologies developer GenomeDx Biosciences has closed an undisclosed amount of Series A round of financing.

The company said on Monday that the funding was led by Baird Venture Partners and Aeris Capital AG. The round includes investments from CD Ventures and other individual investors.

Founded in 2007 by Tim Triche, a member of BVP's advisory board, GenomeDx develops and sells molecular diagnostic tests and clinical support tools for personalized medicine applications in clinical cancer care.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.